Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anrikefon for Postoperative Pain Management in Laparoscopic Cholecystectomy
NCT07741188Phase 2Not yet recruiting
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Phase 2, randomised trial of hsk21542 in postoperative pain (2 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoint: Quality of Recovery-15 scale at 24 hours. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
hsk21542
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07741188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07741188.